Filing Details
- Accession Number:
- 0001567619-21-004320
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-17 19:14:46
- Reporting Period:
- 2021-02-12
- Accepted Time:
- 2021-02-17 19:14:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1559053 | Prothena Corp Public Ltd Co | PRTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1587114 | Ecor1 Capital, Llc | 357 Tehama Street #3 San Francisco CA 94103 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2021-02-12 | 62,500 | $20.50 | 9,489,140 | No | 4 | P | Indirect | See Note 1 |
Ordinary Shares | Acquisiton | 2021-02-12 | 282,800 | $20.08 | 9,771,940 | No | 4 | P | Indirect | See Note 1 |
Ordinary Shares | Acquisiton | 2021-02-16 | 89,200 | $22.78 | 9,861,140 | No | 4 | P | Indirect | See Note 1 |
Ordinary Shares | Acquisiton | 2021-02-17 | 198,840 | $23.46 | 10,059,980 | No | 4 | P | Indirect | See Note 1 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Note 1 |
No | 4 | P | Indirect | See Note 1 |
No | 4 | P | Indirect | See Note 1 |
No | 4 | P | Indirect | See Note 1 |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Call Option | Acquisiton | 2021-02-17 | 2,500 | $3.68 | 250,000 | $30.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2021-02-17 | 2021-06-30 | No | 4 | P | Indirect |
Footnotes
- The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
- All of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 7,915,587 Ordinary Shares.
- All of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,198,387 Ordinary Shares.
- 80,040 of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,278,427 Ordinary Shares.
- 166,926 of the Ordinary Shares purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 8,445,353 Ordinary Shares.
- 2,099 of the options purchased in this transaction were purchased by Qualified Fund. After this transaction, Qualified Fund owned 2,099 options to acquire 209,900 Ordinary Shares.